『HCPLive Podcasts』のカバーアート

HCPLive Podcasts

HCPLive Podcasts

著者： HCPLive.com
無料で聴く

このコンテンツについて

 Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.



 政治・政府 生物科学 科学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • New Insight: The eSight Go with Roland Mattern, eSight Director of Marketing

    New Insight: The eSight Go with Roland Mattern, eSight Director of Marketing
    2025/07/08
    In this episode of New Insight, host Veeral Sheth, MD, MBA, director of clinical research at University Retina and Macula Associates, speaks with Roland Mattern, director of marketing for eSight, about the development and clinical potential of the eSight Go – a fifth-generation wearable low-vision device designed to enhance central visual function in patients with conditions such as macular degeneration, diabetic retinopathy, and Stargardt’s disease.

    00:00 - Intro
    02:06 - History of eSight
    05:43 - Difference Between 4th and 5th Generation eSight Go
    07:51 - Patient Experiences with the eSight Go
    10:22 - Returning to Daily Life with the eSight Go
    13:27 - Why Retina Specialists Don't Hear About the eSight Go
    17:07 - Next Steps for eSight
    続きを読む 一部表示
    21 分
  • HCPLive 5 Stories in Under 5: Week of 06/22

    HCPLive 5 Stories in Under 5: Week of 06/22
    2025/06/30
    Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let’s dive into the latest updates impacting clinicians and healthcare providers like you!

    Interested in a more traditional, text rundown? Check out the HCPFive!

    Top 5 Healthcare Headlines for June 16-22, 2025:
    Pemvidutide Shows Significant MASH Effects, Weight Loss at 24 Weeks in Phase 2b IMPACT Trial
    Topline phase 2b data show pemvidutide achieved significant rates of MASH resolution and fibrosis improvement alongside meaningful weight loss at 24 weeks, positioning it as a promising candidate for metabolic liver disease treatment.

    FDA Approves Belimumab (Benlysta) Autoinjector for Pediatric Lupus Nephritis
    The FDA approved a belimumab autoinjector for at-home subcutaneous use in children as young as five with active lupus nephritis, providing the first approved biologic self-injection option for pediatric SLE and LN.

    Phase 3 Trial Results Announced for Sotatercept-csrk in Pulmonary Arterial Hypertension
    Positive phase 3 results show sotatercept-csrk added to background therapy reduced time to clinical worsening events in adults with PAH, supporting its potential as an effective treatment for this high-risk population.

    Compass Pathways’ COMP360 Psilocybin Shows Benefit in Phase 3 TRD Trial
    COMP360 psilocybin demonstrated a significant reduction in depression symptom severity in treatment-resistant depression, meeting the primary endpoint in a pivotal phase 3 trial.

    Once-Monthly Obesity Drug, MariTide, Achieves Weight Loss Up to 16% at 1 Year
    Phase 2 data indicate once-monthly MariTide induces substantial weight loss of up to 16% over one year, with additional improvements in glycemic control, highlighting its promise for obesity and type 2 diabetes management.
    続きを読む 一部表示
    5 分
  • Medical Ethics Unpacked: Shifting Vaccine Regulation and Policy, with Jason Schwartz, PhD

    Medical Ethics Unpacked: Shifting Vaccine Regulation and Policy, with Jason Schwartz, PhD
    2025/06/18
    In this episode of Medical Ethics Unpacked, hosts Dominic Sisti and Steve Levine welcome Jason Schwartz, PhD, associate professor at the Yale School of Public Health, for a discussion on vaccine ethics, public health infrastructure, and the challenges of maintaining trust in immunization programs.

    Together, they explore how the COVID-19 pandemic reshaped public attitudes toward vaccines, while also underscoring long-standing tensions between individual autonomy and collective responsibility. Schwartz, whose work focuses on vaccine policy and history, offers perspective on the systems and institutions, such as the CDC's Advisory Committee on Immunization Practices (ACIP), helping to translate scientific evidence into public health recommendations.

    This episode comes at a time when ACIP is once again in the headlines as HHS Secretary Robert F. Kennedy Jr. recently replaced all 17 members with a new slate of individuals, citing concerns about groupthink and conflicts of interest. The move has generated widespread commentary about the role and value of such expert advisory bodies in shaping public health decisions, especially in the face of growing skepticism and political scrutiny.

    Ethical questions about equity, communication, and responsibility are threaded throughout the discussion. The hosts and Schwartz reflect on what it means to make fair vaccine recommendations in the context of incomplete data, and how institutions can maintain public trust amid scientific uncertainty. They also discuss how the infrastructure behind public health decisions—committees, advisory boards, and interagency coordination—can either strengthen or undermine confidence depending on how they function and how well they are understood.

    Chapters
    00:00 – Introduction and Vaccine Policy in Crisis
    03:00 – The Long History and New Politics of Vaccine Skepticism
    09:30 – Erosion of Public Health Infrastructure and Expert Advisory Systems
    14:50 – Why Vaccines Became a Political Flashpoint
    19:10 – Clinician Ethics and the Vaccine-Hesitant Patient
    32:00 – Data, Misinformation, and the Future of Vaccine Trust


    References:

    Stone W. RFK Jr. names new slate of vaccine advisers after purging CDC panel. NPR. Published June 11, 2025. Accessed June 17, 2025. https://www.npr.org/sections/shots-health-news/2025/06/11/nx-s1-5430870/cdc-vaccine-experts-rfk-jr

    Asturias EJ, Brewer NT, Brooks O, et al. Advisory Committee on Immunization Practices at a Crossroads. JAMA. Published online June 16, 2025. doi:10.1001/jama.2025.10776
    続きを読む 一部表示
    46 分

HCPLive Podcastsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。